You are here

  • Home
  • Archive
  • Volume 27, Issue 5
  • Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor–Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor–Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer

 

Online download statistics by month:

Online download statistics by month: January 2019 to April 2024

AbstractFullPdf
Jan 2019200
Feb 20199204
Mar 20194200
Apr 20198000
May 20198805
Jun 20199004
Jul 20198002
Aug 20194400
Sep 20196000
Oct 20195303
Nov 20199003
Dec 20194401
Jan 202011600
Feb 20206601
Mar 20203300
Apr 20204403
May 202010402
Jun 20204403
Jul 20204901
Aug 20203600
Sep 20206503
Oct 20204302
Nov 20201800
Dec 20202900
Jan 20213500
Feb 20214700
Mar 20216300
Apr 20217502
May 20215101
Jun 2021200
Jul 2021101
Aug 2021002
Sep 2021100
Oct 20213900
Nov 20214700
Dec 20214500
Jan 20226804
Feb 20225801
Mar 20223800
Apr 20225501
May 20225900
Jun 20226800
Jul 20226000
Aug 20228701
Sep 20226201
Oct 20226301
Nov 20227401
Dec 20224400
Jan 20235201
Feb 20236602
Mar 20236302
Apr 20239001
May 20233300
Jun 20234403
Jul 20233401
Aug 20233400
Sep 20232701
Oct 20236900
Nov 20238300
Dec 20233102
Jan 20243700
Feb 20246003
Mar 20244400
Apr 20244502
Total3366071